Published
Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction
, , ,
Published in October 2025 Issue 10 (Vol. 13, Issue 10, 2025)
Abstract
ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.
Authors (4)
Namitha Rachel Biji
View all publications →Dr. S.K Mathew
View all publications →Dhanu Josey
View all publications →Joseph John
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
October 2025 Issue 10 (Vol. 13, Issue 10, 2025)Article Impact
Views:2,319
Downloads:2,075
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Rachel Biji, N., S.K Mathew, D., Josey, D., & John, J. (2025). Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction. American Journal of Pharmacy and Health Research, 13(10), 1-4. https://doi.org/10.5281/zenodo.17875587